These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 27179966)
41. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models. Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885 [TBL] [Abstract][Full Text] [Related]
42. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887 [TBL] [Abstract][Full Text] [Related]
43. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Buchsbaum MS; Hazlett EA Schizophr Bull; 1998; 24(3):343-64. PubMed ID: 9718628 [TBL] [Abstract][Full Text] [Related]
47. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Onwordi EC; Halff EF; Whitehurst T; Mansur A; Cotel MC; Wells L; Creeney H; Bonsall D; Rogdaki M; Shatalina E; Reis Marques T; Rabiner EA; Gunn RN; Natesan S; Vernon AC; Howes OD Nat Commun; 2020 Jan; 11(1):246. PubMed ID: 31937764 [TBL] [Abstract][Full Text] [Related]
48. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach. Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073 [TBL] [Abstract][Full Text] [Related]
49. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Brans RG; van Haren NE; van Baal GC; Schnack HG; Kahn RS; Hulshoff Pol HE Arch Gen Psychiatry; 2008 Nov; 65(11):1259-68. PubMed ID: 18981337 [TBL] [Abstract][Full Text] [Related]
51. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs. Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023 [TBL] [Abstract][Full Text] [Related]
52. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia. Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310 [TBL] [Abstract][Full Text] [Related]
53. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490 [TBL] [Abstract][Full Text] [Related]
54. The crosstalk between 5-HT Saha S; González-Maeso J Neuropharmacology; 2023 Jun; 230():109489. PubMed ID: 36889432 [TBL] [Abstract][Full Text] [Related]
55. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204 [TBL] [Abstract][Full Text] [Related]
56. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028 [TBL] [Abstract][Full Text] [Related]
57. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474 [TBL] [Abstract][Full Text] [Related]
58. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia. Lerond J; Lothe A; Ryvlin P; Bouvard S; d'Amato T; Ciumas C; Daléry J; Poulet E; Saoud M J Clin Psychopharmacol; 2013 Feb; 33(1):84-9. PubMed ID: 23277246 [TBL] [Abstract][Full Text] [Related]
59. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013 [TBL] [Abstract][Full Text] [Related]
60. P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ. Schmitt U; Lee DE; Herth MM; Piel M; Buchholz HG; Roesch F; Hiemke C; Lueddens H; Debus F Neuropsychobiology; 2011; 63(3):183-90. PubMed ID: 21304228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]